Clinically Actionable Genotypes Among Brazilians
- 5 March 2014
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 96 (1) , 25-26
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pharmacogenomic Implications of Population Admixture: Brazil as a Model CasePharmacogenomics, 2014
- Clinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic TestingClinical Pharmacology & Therapeutics, 2013
- CYP3A5 Genotype, but Not CYP3A4*1b, CYP3A4*22, or Hematocrit, Predicts Tacrolimus Dose Requirements in Brazilian Renal Transplant PatientsClinical Pharmacology & Therapeutics, 2013
- Pharmacogenetics in the Brazilian PopulationFrontiers in Pharmacology, 2010
- Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian PatientsClinical Pharmacology & Therapeutics, 2008